2 months Nektar Therapeutics (NKTR) Reports Q3 Loss, Tops Revenue Estimates Zacks
Nektar (NKTR) delivered earnings and revenue surprises of 21.74% and 55.24%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
X